3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Primary Myelofibrosis
4
Leukemia, Myeloid, Acute
4
Myelodysplastic Syndromes
3
Polycythemia Vera
2
Neoplasms
2
Myeloproliferative Disorders
2
Lymphoma, T-Cell
2
Leukemia
2
Graft vs Host Disease
2
Thrombocythemia, Essential
1
Thalassemia
1
Preleukemia
1
Precancerous Conditions
1
Neoplasms by Histologic Type
1
Myelodysplastic-Myeloproliferative Diseases
1
Mycosis Fungoides
1
Multiple Myeloma
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, B-Cell
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Immunoblastic Lymphadenopathy
1
Hematologic Neoplasms
1
Hematologic Diseases
1
Glioma
1
Glioblastoma
1
Carcinoma, Non-Small-Cell Lung
1
Bronchiolitis Obliterans Syndrome
1
Bone Marrow Diseases
1
Interventions
Carboplatin
3
fludarabine
2
Radiotherapy, Intensity-Modulated
2
Pemetrexed
2
Cyclophosphamide
2
Cisplatin
2
Cerebral Decortication
2
pembrolizumab
1
fludarabine phosphate
1
decitabine and cedazuridine drug combination
1
Platinum
1
Nivolumab
1
Ipilimumab
1
Fluorodeoxyglucose F18
1
Blood Component Removal
1
Bevacizumab
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Mesothelioma
×
ruxolitinib
×
30 days
×
Clear all
No trials found.